How damaging proteins form

Alzheimer's disease and Parkinson's disease are both examples of amyloid diseases, where malfunctioning proteins accumulate to form fibrils and larger aggregates called amyloid plaques. In the journal Biophysical Chemistry ...

Templating S100A9 amyloids on Aβ fibrillar surfaces revealed

A research team lead by Ludmilla Morozova Roche at Umeå University, Sweden, has provided the mechanistic insight into protein co-aggregation in Alzheimer's disease. The templating mechanism of S100A9 amyloids on Aβ fibrillar ...

Gold nanoparticles uncover amyloid fibrils

EPFL scientists have developed powerful tools to unmask the diversity of amyloid fibrils, which are associated with Alzheimer's disease and other neurodegenerative disorders. The scientists made the breakthrough by developing ...

Study probes interplay of proteins in type 2 diabetes

A hallmark of age-related diseases such as Parkinson's disease, type 2 diabetes, or Alzheimer's disease is the abnormal clumping of proteins in cells. In people with these conditions, these protein clumps can result in irregular ...

Protein chains that self-form into helical braids

A team of researchers from Durham University in the U.K. and Shaanxi Normal University in China has discovered a type of protein that forms naturally into two main types of helical braids. In their paper published in the ...

A boundary dance of amyloid-β stepping into dementia

Alzheimer's disease is caused by aggregates of amyloid-β (Aβ) peptides. This aggregation is accelerated at the cell membrane surface. Using molecular dynamics simulations and NMR experiments, the research group at ExCELLS ...

Chemists develop new method for selective binding of proteins

A new method of selectively binding proteins to nanoparticles has been described by a team of German and Chinese researchers headed by Prof. Bart Jan Ravoo, a chemist at the University of Münster (Germany). The nanoparticles ...

page 2 from 4